- FRC 2027: SFG Residential program | accepting application for Tranche-2 Click Here to know more →
- CSAT Classes for Prelims 2027 by Rishi Bhargav sir starts 16 Nov. at 5 PM Click Here to know more →
- Prelims Sprint classes 2027: Starts 2nd Nov. at 4:30 PM | First class open to all. Click Here to know more →
Source: The post is based on the article “DRDO-developed technology behind critical drug approved by DCGI for radiological and nuclear emergencies” published in The Hindu on 16th March 2023
What is the News?
The Defence Ministry has announced that the Prussian blue insoluble formulations drug has been granted approval by the Drugs Controller General of India(DCGI).
What is a Prussian blue insoluble formulation drug?
It is one of the critical medicines listed by the World Health Organisation(WHO) for radiological and nuclear emergencies.
It is used to treat the symptoms of Cesium or Thallium Contamination.
The drug was developed under the Technology Development Fund(TDF).
The drug has been developed based on the technology of the Institute of Nuclear Medicine and Allied Sciences (INMAS), Delhi, a laboratory of the DRDO.
